Page 2,983«..1020..2,9822,9832,9842,985..2,9903,000..»

A Citizens Guide To Artificial Intelligence: A Nice Focus On The Societal Impact Of AI – Forbes

Artificial Intelligence

A Citizens Guide to Artificial Intelligence, by a cast of thousands (John Zerilli, John Danaher, James Maclaurin, Colin Gavaghan, Alistair Knott, Joy Liddicoat, and Merel Noorman) is a nice high level view of some of the issues surrounding the adoption of artificial intelligence (AI). The author bios describe them as all lawyers and philosophers except for Noorman, and with that crowd its no surprise the book is much better at discussing the higher level impacts than AI itself. Luckily, theres a whole lot more of the latter than there is the former. The real issue is theyre better at explaining things than at coming to logical conclusions. Well get to that, but its still a useful read.

The issue about understanding of AI is shown early, when they first give a nice explanation of false positives and false negatives, but then write Its hard to measure the performance of unsupervised learning systems because they dont have a specific task. As this column has repeatedly mentioned, the key use of unsupervised learning is the task of detecting anomalous behavior, especially when anomalies are sparse. The difference between supervised and unsupervised learning is in knowing what youre looking for:

Supervised: Hey, heres attack XYZ!

Unsupervised learning: Hey, heres this weird thing that might be an attack!

So skim chapter one to get to the good stuff. Chapter two is about transparency, and Figure 2.1 is a nice little graphic about the types of transparency they are describing. What I really like is that accessibility is in the top tier. It doesnt matter if the designers and owners of a system are claiming to be responsible and are also inspecting the results to check accuracy; if the information isnt accessible to all parties involved in and impacted by the AI system, theres a problem.

The one issue I have with the transparency chapter is in the section human explanatory standards. They seem to be claiming that since were hard to understand, why should we expect better from AI systems? They state, A crucial premise of this chapter has been that standards of transparency should be applied consistently, regardless of whether were dealing with humans or machines. Yes, a silly premise. We didnt create ourselves. Were building AI systems for the same reasons weve built other thing in order to do things easier or more accurately than we can do them. Since were building the system, we should expect to be able to require more transparency to be built into a system.

The next three chapters are on bias, responsibility & liability, and control. They are good overviews of those issue. The control chapter is intriguing because its not just about us controlling the systems, but also covers issues about giving up control to systems.

Privacy is a critical issue, and chapter six is nice coverage of that. The most interesting section is on inferred data. We talk about inference engines, making inferences on the data; but the extension of that to privacy is to say there might be ethical limits to what engines should be allowed to infer. Theres the old case of a system knowing a young woman is pregnant and sending pregnancy sales pitches to her home before she had told her parents, but there are far worse situations. Consider societies that are intolerant of sexual orientation, but that can be inferred from other data. A government could use that to persecute people. Theres a wide spectrum in between those examples, and the chapter does a nice job of getting people to think about the issue.

The next chapter covers autonomy and makes some very good points. One is that humans have always challenged each others autonomy, but that AI and lack of laws and regulations make it far easier for governments and a few companies to remove our autonomy in much more opaque ways than have previously been available.

Algorithms in government and employment are given a good introduction in the next chapters, but with a lot of the same information seen elsewhere. The most interesting part of the back portion of the book comes in chapter ten, about oversight and regulation. There is a suggestion that, given the complexity of AI, there is logic to creating a new oversight agency for the national government. As they point out, an FDA for AI. Think of it in business terms, its a center of excellence in AI, able to formulate national policy for business and citizens, while also serving to help other agencies adapt the general policies to their specific oversight areas. That makes excellent sense.

No book is perfect, but Im partially surprised that a book with so many authors attached flows as well. Then I remember they all are academics, used to research papers with multiple authors. Of course, with that many academics, the risk is always that a book will sound like a research paper. Fortunately, they seem to have escaped that problem. A Citizens Guide is a good read to help people understand key issues in having AI make the major impact on society that it will. More people need to realize that quickly and get governments to focus on protecting people.

Continue reading here:
A Citizens Guide To Artificial Intelligence: A Nice Focus On The Societal Impact Of AI - Forbes

Read More..

Artificial Intelligence used to Automate Assessment of Mesothelioma – The FINANCIAL

The FINANCIAL -- Patients receiving treatment for the asbestos cancer, Mesothelioma, are being assessed with Artificial Intelligence (AI) as part of a prototype imaging system which could revolutionise the way people with the disease are cared for. Scotland currently has the highest incidence of Mesothelioma in the world, a reflection of the historical use of asbestos in many UK industries, including shipbuilding and construction.

Canon Medical Research Europe, a Scottish firm specialising in next generation medical imaging software, and the University of Glasgow are set to publish clinical findings from a study evaluating a new, world-leading AI-driven cancer assessment tool, developed as part of the Cancer Innovation Challenge.

The study team, which comprises AI and data scientists at Canon Medical and University of Glasgow clinical researchers based at the Queen Elizabeth University Hospital, and NHS Greater Glasgow and Clyde Research and Innovation staff, created a prototype AI system able to automatically find and measure Mesothelioma on CT scans, which are used to assess patients response to drug treatments like chemotherapy. The AI was trained by showing it over 100 CT scans, on which an expert clinician had drawn around all areas of the tumour showing the AI what to look for. The trained AI was then shown a new set of scans and was able to find and measure the tumour extremely accurately, without any human input,University of Glasgow notes.

The tool, which could revolutionise the fight against cancer, intentionally focused on Mesothelioma given its prominence in Scotland and because it is one of the most difficult-to-measure cancers on CT scans. This is because it grows like a rind around the surface of the lung, forming a complex shape - rather than a round ball like most tumours. The successful results of the project will provide a strong foundation for similar tools to be developed in the assessment of other cancers.

At present, treatment options for Mesothelioma are limited and clinical trials are critical for discovery of new, more effective treatments. The AI tool streamlines tumour measurements, potentially making clinical trials of new drugs less expensive, less time-consuming and more accurate. After further validation work, which is now ongoing as part of an international accelerator network funded by Cancer Research UK, the AI tool may soon be available to help doctors measure Mesothelioma on scans during treatment with greater precision and at a reduced cost.

Keith Goatman, Principal Scientist at Canon Medical, said: The speed and accuracy of the AI algorithm could have a wide-reaching impact on Mesothelioma treatment. Accurate tumour volume measurements are much too time-consuming to perform by hand. Automating these measurements will open the way for clinical trials of new treatments, by detecting even small changes in the tumour size. Ultimately, it could be used routinely in hospitals to decide the best treatment for each individual.

The funding and support from the Cancer Innovation Challenge has been vital in bringing this idea to life, and we are looking forward to continuing our work with the excellent team at the University of Glasgow in the years to come. This work is a strong first step towards real change in the treatment of all cancers not just Mesothelioma.

Professor Kevin Blyth, Professor of Respiratory Medicine in the University of Glasgow, and Honorary Consultant Respiratory Physician at Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, said: To our knowledge, this study is world-leading in its successful use of AI to assess treatment response in Mesothelioma. Using external data sets to validate our results, we have shown that tumours can be accurately measured by AI, giving us a new tool that will help us make better decisions for patients on treatment and reducing barriers to development of new treatments in clinical trials,University of Glasgow notes.

The results, which are testament to the expertise of Canon Medical and made possible by the Cancer Innovation Challenge funding, have acted as a springboard towards our next project, the PREDICT-Meso Accelerator, which is now allowing us to further develop the AI so that it can start benefiting patients soon.

Launched in 2017, the Cancer Innovation Challenge is a 1 million project funded by the Scottish Government through the Scottish Funding Council to encourage collaboration between innovation centres, medical professionals and cutting-edge healthcare businesses to help Scotland become a world-leader in cancer care.

The project brings together three Innovation Centres, led by The Data Lab in collaboration with Digital Health and Care Institute (DHI) and Precision Medicine Scotland.

Steph Wright, Director of Health & Wellbeing Engagement at The Data Lab, added: The work to develop this world-leading tool from Canon Medical and the University of Glasgow, represents an incredibly exciting healthcare innovation. Not only does it have the potential to revolutionise Mesothelioma cancer care through more targeted treatment, but it may also be able to be applied to a number of other cancer types in the future.

Its been a privilege to play a part in helping to deliver the Scottish Funding Councils Cancer Innovation Challenge initiative, supporting and spotlighting the companies carrying out valuable work that can help make Scotland a leader in data-driven cancer support. Through projects like this, we really can show that data saves lives.

Following publication of the initial study results, the team will continue to work together, supported by part of a 5million funding award made by CRUK, for the PREDICT-Meso Accelerator led by Prof Blyth. In addition to AI optimisation, this project aims to understand how asbestos-driven inflammation develops into Mesothelioma and develop new treatments for the disease. Canon Medical is a key collaborator on this project,University of Glasgow notes.

Read the original:
Artificial Intelligence used to Automate Assessment of Mesothelioma - The FINANCIAL

Read More..

Proteins, artificial intelligence, and future of pandemic responses – Dailyuw

The Institute for Protein Design (IPD) at the UW announced March 31 a $5 million grant from Microsoft to collaborate on applying artificial intelligence to protein design.

Microsofts chief scientific officer Eric Horvitz and the IPDs director David Baker, in an article with GeekWire, said they believe that this collaboration will lead to major strides in medicine and technology, and accelerate the scientific response to future pandemics.

The IPD designs proteins molecules that carry out a wide range of functions from defending against pathogens to harnessing energy during photosynthesis from scratch, with the goal of making a whole new world of synthetic proteins to address modern challenges, according to the institutes website.

Researchers at the IPD have developed promising anti-viral and ultra-potent vaccine candidates against SARS-CoV-2, the virus that causes COVID-19, that are currently in human clinical trials.

And in protein design, form follows function.

We use 3D protein structures on the computer to design the protein sequences, Brian Coventry, a research scientist in the Baker Lab at the IPD, said. When we order the protein sequence, its function in real life should exactly mirror that on the computer.

But that does not always happen.

The problem with this method, which is based on the first principles of both physics and chemistry, is that it produces an abundance of possible proteins which must be tested, the majority of which do not have the exact desired form, Coventry said.

Coventry recently worked on a team that developed a SARS-CoV-2 antiviral medication candidate, and he stressed that for antivirals, it is important that the designed protein be precisely atomically correct.

In the context of a pandemic, the fast development of highly accurate therapeutic synthetic proteins is desirable. This is where deep learning, a subset of artificial intelligence modeled after the brains neural networks, comes into play.

There is a lot of room for improvement, Minkyung Baek, a postdoctoral scholar in the Baker Lab at the IPD, said about the first principles-based method of protein design. Baek believes that deep learning methods can be used to quickly discriminate between possible proteins and optimize design to produce proteins that are more stable and bind more tightly to targets.

Deep learning models are given a training data set, in this case experimental results of the structures of designed proteins, and then can learn based on real-world data. They use that information to predict and design protein structures, Baek said.

Microsoft has given the IPD access to their cloud computing service Azure, which will enable them to train and test deep learning models about 10 times faster, according to Baek.

Baek hopes that this will speed up the development of effective deep learning models, which will be helpful not only for designing proteins that match existing biological proteins, but also for discovering the structure of naturally occurring proteins.

There are many real-world situations where the structure of the target is not precisely known. In these situations, researchers must predict the shape of the metaphorical lock and design the key simultaneously.

Being able to better predict the structure of a protein when given its genetic code is important, with Baek using the variants of the COVID-19 virus as an example.

Using our deep learning base, we can predict the protein structure of the variant, and starting from there we may get some clue [about] why that variant may have been more severe or easy to spread, Baek said.

But these deep learning models have some limitations. They are limited by the available training data set, are not always generalizable to multiple situations, and do not explain the reasoning behind their decisions, Coventry said.

Despite these factors, Coventry and Baek are both optimistic about the potential for deep learning to improve the protein design process.

At the end of the day, Id like to see a 100% success rate, you know, Coventry said. Someday Im sure its possible.

Reach reporter Nuria Alina Chandra at news@dailyuw.com. Twitter: @AlinaChandra

Like what youre reading? Support high-quality student journalism by donatinghere.

Read more here:
Proteins, artificial intelligence, and future of pandemic responses - Dailyuw

Read More..

Johnson Controls and Pelion Partner on Artificial Intelligence / Internet of Things (AIoT) For Smart, Healthy, and Sustainable Buildings – IoT For All

ByPelion Press Team

Today,Pelion, theConnected IoT Device service provider, and subsidiary of Arm, jointly announced a partnership withJohnson Controls(NYSE: JCI), the global leader for smart, healthy and sustainable buildings. This partnership will accelerate innovation in connectivity, security and intelligence at the edge for Johnson Controls OpenBlue technology.

This partnership combines Johnson Controls deep domain expertise in healthy buildings with Pelions device and edge management capabilities to usher in an era of truly smart, updatable facilities at cloud scale. OpenBlues AI capabilities at the edge will consolidate diverse points of intelligence distributed across various floors, sites or even continents into insights and actions, creating an updatable building that can self-heal and evolve over its lifespan.

This innovation mirrors the automotive sector, where software, multiple sensors and AI-trained models have transformed the industry by enabling autonomous driving and software updates that blend data to continually improve vehicle capabilities and experience. Johnson Controls is applying the concept to the built environment. They will leverage Pelions flexible device management capabilities to unite diverse device types and application layers to feed AI models that respond to dynamic workloads.

Johnson Controls has the strategic foresight to rely on a partner to streamline the complexity of IoT device management security and secure firmware updates over the air. Pelions connected device platform will standardize the onboarding process for all systems, including the edge and endpoint devices that run on them, plus offer world-class public key infrastructure for secure and simple integration with third-parties.

This secure, open and flexible approach to device management will allow OpenBlue to run any device and hardware configuration, from hardware gateways to constrained temperature sensors.

In order to provide sustainable, low cost and low power intelligent processing at the edge, the partnership will utilize proven energy-efficient processors from Pelions parent company, Arm, which are a key part of Johnson Controls distributed hardware deployment.

Read more about the future of smart, healthy, and sustainable buildings in this blog.

Go here to read the rest:
Johnson Controls and Pelion Partner on Artificial Intelligence / Internet of Things (AIoT) For Smart, Healthy, and Sustainable Buildings - IoT For All

Read More..

Judge signals that artificial intelligence cannot be named as an inventor in the United States – JD Supra

The ongoing artificial intelligence (AI) inventorship case of Thaler v. Iancu, et al. (No. 1:20-cv-00903) took another turn on April 6th when U.S. District Court Judge Leonie Brinkema of the Eastern District of Virginia signaled she may rule that AI systems cannot be listed as inventors on U.S. patent applications. Plaintiff Dr. Stephen Thaler is the inventor of an AI system named DABUS, which went on to allegedly invent the subject-matter of two patent applications filed at the United States Patent and Trademark Office (USPTO). Following the USPTOs rejection of the applications on the grounds that the applications were deficient and an AI system cannot be listed as an inventor, Thaler filed a lawsuit against the USPTO in 2020. It should be noted that both the USPTO and Thaler agree that Thaler himself apparently could not be listed as the inventor of the subject-matter of the patent applications.

At a summary judgment hearing in the case, Judge Brinkema stated that Plaintiff Thaler has a huge uphill battle . . . because the statutory language [of the Patent Act] is so crystal clear that an inventor must be living individual, and not a machine. Judge Brinkema further stated that it is the job of legislatures, not the courts, to address such issues as technology rapidly advances; Courts are not legislatures . . . and I think ultimately what youre asking this court to do is legislate.

The potential effects a ruling in favor of Thaler would have on other areas of patent law also arose at the hearing in the context of patent assignments. Specifically, Judge Brinkema questioned how an AI system could assign rights in an invention to which it is named when the assigning party must have intent to assign the rights.

While it remains to be seen how Judge Brinkema will rule, it is likely that the ball will be kicked over to Congress to determine how to handle inventorship by AI systems. Given the tremendous leaps forward that AI has made in the past decade alone, this issue is likely to continue until changes are made to the Patent Act.

[View source.]

Read this article:
Judge signals that artificial intelligence cannot be named as an inventor in the United States - JD Supra

Read More..

Future Role of Artificial Intelligence in Logistics and Transportation – IoT For All

As logistics and freight organizations become more digitized, enterprises will be able to collect increasing amounts of data surrounding their customers, supply chain, deliveries, fleet, drivers, and more.Leading logistics organizations are already harnessing Artificial Intelligence (AI) in transportation. While a lot of enterprises currently collect this data, which will only continue to increase in the future, this data is still massively underutilized.

Using the power of AI, enterprises can unlock advanced route planning that optimizes several real-world factors in a way thats difficult or impossible for traditional route planning to do.

Traditional route planning factors in transportation can typically only incorporate a few factors, which are still very naive rule-based factors. However, traditional ways cant just be replaced overnight. The entire procedure of adapting to a new technology requires time and skills to be acquired.

To enable efficient route planning with AI, enterprises need to account for a wide variety of factors. Factors include the type that is to be delivered, customer preferences, traffic patterns, local road regulations, and changing routing behaviors in addition to subjective factors such as local knowledge of delivery personnel and other preferences.

With predictive analytics, an AI-powered system can optimize real-world factors for route planning that results in a lower cost of deliveries, faster delivery times, reduced shipping costs, and better asset utilization. Predictive analytics use data, statistical algorithms, and machine learning to identify the likelihood of future outcomes based on historical data.

In the future, AI-based systems will help unlock the true potential power of enterprise data. This will enable better customer experiences, improved fleet management, faster deliveries, lower safety incidents, and better overall business margins. AI enables a win-win scenario for all stakeholders in the logistics transportation ecosystem but requires some effort and investment to build and maintain.

As important as AI is, an underrated component of AI is data and data engineering. Data engineering is the aspect of data science that focuses on practical applications of data collection and analysis. Before jumping onto the AI hype train, ask yourself, are you collecting critical data about your business operations? Is the data effectively stored, organized, and easily accessible?

At the end of the day, while AI is currently a trending tech buzzword, its only useful to solve an actual business problem. Assess what problems you want AI-based systems to solve, adopt them into your business goals, and use the proper metrics to measure efficiencies.

Read the original post:
Future Role of Artificial Intelligence in Logistics and Transportation - IoT For All

Read More..

Top Trader Scott Melker Analyzes Ethereum, XRP and Litecoin, Predicts Massive Altcoin Breakout Against Bitcoin – The Daily Hodl

Crypto strategist Scott Melker is detailing his current outlook on Bitcoin, Ethereum, Litecoin and XRP.

Melker says BTCs dip to around $62,000 after Coinbase hit the stock market on Wednesday is no surprise.

Thats a really, really classic textbook trade, something like that. Now, as you know, when youre trading these, you dont put it exactly on the line, you spread orders above, below, right at the line, so that you catch it. You might not fill a full position, but you also dont want to get front-run by whales.

If for some reason Bitcoin breaks below that $62,000 level, Melker says hed be looking for a trade right around the $60,000 area as a retest.Melker remainsbullish on BTC, although hes anticipating outsized returns in the altcoin market.

Bitcoin is the most important asset ever created. If I had to choose one thing to hold, it would be BTC. That said, if you are a TRADER (not investor), the disproportionate upside from this point is likely in altcoins. They are far more likely to make you insanely wealthy.

As a primary example, Melker says Ethereum is quietly breaking out against BTC and showing no signs of stopping. He was hoping to execute a trade in the $2,200 area, but so far the second-largest cryptocurrency hasnt looked back.

The trader is predicting Litecoin (LTC) will hit $347 in the short term. LTC is trading at $273.75 at time of writing, according to CoinGecko.

Melker is also bullish on XRP, noting that the U.S. Securities and Exchange Commissions (SEC) lawsuit against Ripple now appears to be boosting the assets price.

Its amazing what happens when the company is not selling and those coins are removed from the supply. You have tons of demand, FOMO (fear of missing out), and no huge players selling into it. So I believe thats why were seeing this continued strength and it could continue to keep going if the FOMO remains

To me right now, any dip on XRP is probably for buying.

XRP is trading at $1.77 at time of writing, nearly a 92% increase over the past seven days, according to CoinGecko.

Featured Image: Shutterstock/Wutana Thongkuanluek

Read the original post:
Top Trader Scott Melker Analyzes Ethereum, XRP and Litecoin, Predicts Massive Altcoin Breakout Against Bitcoin - The Daily Hodl

Read More..

Crypto Trader Ben Armstrong Is Buying $100,000 Worth of This Red-Hot Altcoin – The Daily Hodl

Widely-followed crypto trader and analyst Ben Armstrong says hes heavily accumulating one large-cap altcoin as it continues to show signs of strength.

In a new video, Armstrong tells his 795,000 YouTube subscribers that hes buying at least $100,000 worth of Binance Coin (BNB).

I will tell you that I have been buying the **** out of some Binance Coin lately. Its the one major coin outside of XRP that I wasnt holding. I have changed that I think we now have six figures in Binance Coin.

In addition to Binance Coin, Armstrong reveals that hes building positions in four other crypto assets.

Polkadot (DOT) is another one were going to be adding some more, too. I bought some Solana (SOL) last night. I bought some Elrond (EGLD) last night. Harmony (ONE) is next on my list to buy.

The trader is also keeping a close watch on Ethereum, which he says is gearing up for a massive breakout as it continues to flash signs of bullishness.

Ethereum right now is looking very strong and even when Bitcoin drops. This is when you know Ethereum is gearing up for big moves. Bitcoin has dropped and Ethereum has not really been flinching. Its been staying above $2,100 Its looking like the network effects of Ethereum are bearing out.

At time of writing, Ethereum is trading at $2,393, up over 10.71% in the last 24 hours, according to CoinMarketCap.

I

Featured Image: Shutterstock/SimpleB

Go here to see the original:
Crypto Trader Ben Armstrong Is Buying $100,000 Worth of This Red-Hot Altcoin - The Daily Hodl

Read More..

The EOS Cryptocurrency Is the Top Altcoin to Watch Now – Money Morning

EOS, the cryptocurrency behind EOS.IO, could be one of the hottest cryptocurrencies of 2021.

By now, most investors are intimately familiar with Bitcoin. You likely know quite a bit about Ethereum. Even other altcoins like Cardano are catching on.

EOS could be next.

If you're interested in making money from cryptocurrencies, this altcoin absolutely needs to be on your radar.

Here's why

At its heart, EOS is solving problems found on other cryptocurrencies' blockchains.

One of the big problems cryptocurrencies face is that some networks process transactions very slowly. Think about how important that is for people to adopt and use a coin. Even an extra minute in processing a transaction could turn people away from using the coin.

Even the vaunted Bitcoin takes an average of 10 to 20 minutes to process a transaction, according to CryptoVantage. It can even take up to an hour.

That's one of the big reasons Bitcoin has turned into a store of value type of investment instead of a potential rival to the dollar. And it leaves a huge void in the cryptocurrency space for a coin that can rival traditional forms of payment in speed and reliability.

Widespread adoption of cryptocurrencies to solve everyday problems from spending money to exchanging money overseas to smart contracts is the fuel powering cryptocurrency prices higher and higher. A roadblock to adoption by the public is a roadblock to profits.

EOS is trying to fix this.

How to Make Extra Income with Crypto

You could be earning up to 9% in interest on crypto deposits! Learn how to grow your money faster in our new report. Its free!

Thank you for subscribing! Check your email to access your free report.

In fact, its network aims to run millions of transactions per second.

That means it satisfies two of Money Morning top cryptocurrency expert Tom Gentile's main criteria for a profitable cryptocurrency to buy: It offers users value, and it's useful.

As Tom puts it, "I'd say a fast, free blockchain with the ability to eventually process millions of transactions every second of every day qualifies as valuable and useful."

Currently, the EOS price is trading right inside its 52-week average between $2 and just over $7 a coin, sitting right around $6.50.

Tom's not just a cryptocurrency expert, he's an expert trader. He's not just looking for cryptocurrencies with adoption potential he's also looking at their price trends to make sure there's upside potential and it's the right time to buy. For Tom, EOS trading inside its 52-week average is key for investors watching the coin.

"I wouldn't be surprised if big things happen," Tom says.

A surge of interest from institutional investors is setting the stage for a rally in a slew of small digital coins.

But understand this: These under-the-radar players are much more affordable than Bitcoin.

Some are so hot, even a small stake could transform into a humble fortune in 2021.

One is trading for just $5 and could deliver a 328% profit in just a few years.

Our resident Silicon Valley insider is recommending three tiny coins as today's BEST crypto buys to get his take on all three, click here.

Follow Money Morningon Facebook and Twitter.

Join the conversation. Click here to jump to comments

See the original post:
The EOS Cryptocurrency Is the Top Altcoin to Watch Now - Money Morning

Read More..

Balancer (BAL) Price Predictions: Where Will the Balancer Crypto Go After Altcoin Frenzy? – InvestorPlace

Currently, the sentiment in the crypto space is incredibly bullish. Todays IPO of Coinbase (NADSAQ:COIN) has lifted investor expectations to new highs. Accordingly, DeFi tokens like Balancer (CCC:BAL-USD) have been a hot commodity. Balancer (BAL) price predictions have increasingly become bullish, which is expected, given the rapid rise BAL has seen of late.

Today, the Balancer crypto is up more than 15% at the time of writing. These returns are nowhere near what investors in COIN stock are seeing today from the reference price. However, any double-digit day is a good one for investors.

It appears momentum is beginning to build around the Balancer crypto as a top DeFi play. Balancer is increasingly being viewed as a decentralized exchange, or automated market maker, by investors. Given the interest in Coinbase of late, investors are hoping to see some sort of similar returns with other DeFi platforms and tokens over time.

The range of predictions on where Balancer crypto could be headed varies. However, investors will note, the predictions are quite bullish. Accordingly, lets jump into what the experts think about this crypto option today.

As a reference point for the below predictions, Balancer token (BAL) currently trades at $63.

On the date of publication, Chris MacDonald did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Link:
Balancer (BAL) Price Predictions: Where Will the Balancer Crypto Go After Altcoin Frenzy? - InvestorPlace

Read More..